Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

O Neuhaus1, S Strasser-Fuchs, F Fazekas

  • 1Department of Neurology, Multiple Sclerosis Research Group, Karl-Franzens-Universität, Graz, Austria.

Neurology
|October 9, 2002
PubMed
Summary

Statins demonstrate potent immunomodulatory effects in vitro, inhibiting immune cell proliferation and reducing inflammatory markers. These findings suggest statins may be a promising treatment option for multiple sclerosis (MS).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Value of treatment by comprehensive stroke services for the reduction of critical gaps in acute stroke care in Europe.

European journal of neurology·2020
Same author

Correction to: Features of intracranial hemorrhage in cerebral venous thrombosis.

Journal of neurology·2020
Same author

Features of intracranial hemorrhage in cerebral venous thrombosis.

Journal of neurology·2020
Same author

The European Academy of Neurology is 6 years old: challenges, opportunities and strategic priorities for the future.

European journal of neurology·2020
Same author

Ventilation time and prognosis after stroke thrombectomy: the shorter, the better!

European journal of neurology·2020
Same author

[Patient monitoring 4.0].

Der Nervenarzt·2019

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Emerging data indicate statins possess significant immunomodulatory properties.
  • This study investigates statins' immunologic effects in vitro, comparing them with interferon (IFN)beta-1b for potential multiple sclerosis (MS) treatment.

Purpose of the Study:

  • To evaluate the immunomodulatory potential of statins in the context of MS.
  • To compare the in vitro immunologic effects of statins with IFNbeta-1b.

Main Methods:

  • Peripheral blood mononuclear cells (PBMC) and T cells from MS patients and healthy donors were stimulated and treated with lovastatin, simvastatin, mevastatin, or IFNbeta-1b.
  • Analysis included cell proliferation, cytokine production, matrix metalloproteinase (MMP) activity, and surface marker expression on immune cells.

Related Experiment Videos

Main Results:

  • Statins dose-dependently inhibited PBMC proliferation, with simvastatin being most potent.
  • Statins reduced T cell activation markers, modulated T helper 1/T helper 2 cytokine balance, decreased MMP-9, and downregulated chemokine receptors.
  • Combined statin and IFNbeta-1b treatment showed additive inhibitory effects, though some proinflammatory effects were also observed.

Conclusions:

  • Statins exhibit significant immunomodulatory capabilities in vitro.
  • Statins warrant further investigation as a potential therapeutic strategy for MS.